The Question Is Whether To Buy Or Not To Buy Solid Biosciences Inc (NASDAQ: SLDB)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Solid Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Solid Biosciences Inc is $275.87M. A total of 1.54 million shares were traded on the day, compared to an average of 2.59M shares.

In the most recent transaction, Kahn Clare bought 1,860 shares of SLDB for 5.34 per share on Mar 11 ’25. After the transaction, the Director now owns 2,960 company shares. In a previous transaction on Feb 19 ’25, Bain Capital Life Sciences Inv bought 1,000,000 shares at 4.03 per share. SLDB shares that 10% Owner owns now total 5,034,582.

Among the insiders who bought shares, PERCEPTIVE ADVISORS LLC acquired of 5,000,000 shares on Feb 19 ’25 at a per-share price of $4.03. This resulted in the Director holding 11,833,539 shares of SLDB after the transaction. In another insider transaction, Adage Capital Management, L.P. bought 252,545 shares at $7.56 per share on Feb 18 ’25. Company shares held by the 10% Owner now total 4,248,084.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SLDB has a high of $10.99 and a low of $2.45.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $3.39, while its Total Shareholder’s Equity was $208.21M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 5.00.

Most Popular

Related Posts